141 related articles for article (PubMed ID: 8620916)
1. Microencapsulated ciliary neurotrophic factor: physical properties and biological activities.
Maysinger D; Krieglstein K; Filipovic-Grcic J; Sendtner M; Unsicker K; Richardson P
Exp Neurol; 1996 Apr; 138(2):177-88. PubMed ID: 8620916
[TBL] [Abstract][Full Text] [Related]
2. Poly(lactic-co-glycolic acid) nanospheres and microspheres for short- and long-term delivery of bioactive ciliary neurotrophic factor.
Nkansah MK; Tzeng SY; Holdt AM; Lavik EB
Biotechnol Bioeng; 2008 Aug; 100(5):1010-9. PubMed ID: 18431801
[TBL] [Abstract][Full Text] [Related]
3. Effects of the neurotrophins and CNTF on developing statoacoustic neurons: comparison with an otocyst-derived factor.
Bianchi LM; Cohan CS
Dev Biol; 1993 Sep; 159(1):353-65. PubMed ID: 8365572
[TBL] [Abstract][Full Text] [Related]
4. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres.
Perets A; Baruch Y; Weisbuch F; Shoshany G; Neufeld G; Cohen S
J Biomed Mater Res A; 2003 Jun; 65(4):489-97. PubMed ID: 12761840
[TBL] [Abstract][Full Text] [Related]
5. Ciliary neurotrophic factor fused to a protein transduction domain retains full neuroprotective activity in the absence of cytokine-like side effects.
Rezende AC; Peroni D; Vieira AS; Rogerio F; Talaisys RL; Costa FT; Langone F; Skaper SD; Negro A
J Neurochem; 2009 Jun; 109(6):1680-90. PubMed ID: 19457136
[TBL] [Abstract][Full Text] [Related]
6. The hematopoietic cytokine colony stimulating factor 1 is also a growth factor in the CNS: (II). Microencapsulated CSF-1 and LM-10 cells as delivery systems.
Maysinger D; Berezovskaya O; Fedoroff S
Exp Neurol; 1996 Sep; 141(1):47-56. PubMed ID: 8797667
[TBL] [Abstract][Full Text] [Related]
7. Ciliary neurotrophic factor.
Sendtner M; Carroll P; Holtmann B; Hughes RA; Thoenen H
J Neurobiol; 1994 Nov; 25(11):1436-53. PubMed ID: 7852996
[TBL] [Abstract][Full Text] [Related]
8. Astrocytes infected with replication-defective adenovirus containing a secreted form of CNTF or NT3 show enhanced support of neuronal populations in vitro.
Smith GM; Hale J; Pasnikowski EM; Lindsay RM; Wong V; Rudge JS
Exp Neurol; 1996 May; 139(1):156-66. PubMed ID: 8635562
[TBL] [Abstract][Full Text] [Related]
9. Site-directed mutagenesis of human CNTF: functional analysis of recombinant variants.
Thier M; Simon R; Krüttgen A; Rose-John S; Heinrich PC; Schröder JM; Weis J
J Neurosci Res; 1995 Apr; 40(6):826-35. PubMed ID: 7629895
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease.
Emerich DF; Winn SR; Hantraye PM; Peschanski M; Chen EY; Chu Y; McDermott P; Baetge EE; Kordower JH
Nature; 1997 Mar; 386(6623):395-9. PubMed ID: 9121555
[TBL] [Abstract][Full Text] [Related]
11. Prevention of thrombin-induced motoneuron degeneration with different neurotrophic factors in highly enriched cultures.
Turgeon VL; Houenou LJ
J Neurobiol; 1999 Mar; 38(4):571-80. PubMed ID: 10084690
[TBL] [Abstract][Full Text] [Related]
12. Encapsulated cell-based delivery of CNTF reduces photoreceptor degeneration in animal models of retinitis pigmentosa.
Tao W; Wen R; Goddard MB; Sherman SD; O'Rourke PJ; Stabila PF; Bell WJ; Dean BJ; Kauper KA; Budz VA; Tsiaras WG; Acland GM; Pearce-Kelling S; Laties AM; Aguirre GD
Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3292-8. PubMed ID: 12356837
[TBL] [Abstract][Full Text] [Related]
13. A protein delivery system: biodegradable alginate-chitosan-poly(lactic-co-glycolic acid) composite microspheres.
Zheng CH; Gao JQ; Zhang YP; Liang WQ
Biochem Biophys Res Commun; 2004 Oct; 323(4):1321-7. PubMed ID: 15451441
[TBL] [Abstract][Full Text] [Related]
14. Preparation and a structure-function analysis of human ciliary neurotrophic factor.
He C; Chen J; Ao S; Lu C
Neurosci Res; 1995 Nov; 23(4):327-33. PubMed ID: 8602271
[TBL] [Abstract][Full Text] [Related]
15. Ciliary neurotrophic factor activates spinal cord astrocytes, stimulating their production and release of fibroblast growth factor-2, to increase motor neuron survival.
Albrecht PJ; Dahl JP; Stoltzfus OK; Levenson R; Levison SW
Exp Neurol; 2002 Jan; 173(1):46-62. PubMed ID: 11771938
[TBL] [Abstract][Full Text] [Related]
16. CNTF induces raphe neuronal precursors to switch from a serotonergic to a cholinergic phenotype in vitro.
Rudge JS; Eaton MJ; Mather P; Lindsay RM; Whittemore SR
Mol Cell Neurosci; 1996 Mar; 7(3):204-21. PubMed ID: 8726104
[TBL] [Abstract][Full Text] [Related]
17. In vitro characterization of vascular endothelial growth factor and dexamethasone releasing hydrogels for implantable probe coatings.
Norton LW; Tegnell E; Toporek SS; Reichert WM
Biomaterials; 2005 Jun; 26(16):3285-97. PubMed ID: 15603824
[TBL] [Abstract][Full Text] [Related]
18. Polymer encapsulated cell lines genetically engineered to release ciliary neurotrophic factor can slow down progressive motor neuronopathy in the mouse.
Sagot Y; Tan SA; Baetge E; Schmalbruch H; Kato AC; Aebischer P
Eur J Neurosci; 1995 Jun; 7(6):1313-22. PubMed ID: 7582105
[TBL] [Abstract][Full Text] [Related]
19. Neuronal differentiation elicited by glial cell line-derived neurotrophic factor and ciliary neurotrophic factor in adrenal chromaffin cell line tsAM5D immortalized with temperature-sensitive SV40 T-antigen.
Murata T; Tsuboi M; Koide N; Hikita K; Kohno S; Kaneda N
J Neurosci Res; 2008 Jun; 86(8):1694-710. PubMed ID: 18293415
[TBL] [Abstract][Full Text] [Related]
20. Composite microspheres induce the sustained release and the control of the initial release of water soluble drugs.
Chen G; He CX; Xu DH; Liu L; Zhang FJ; Xu JY; Zheng CH; Gao JQ; Yan M
Pharmazie; 2009 Apr; 64(4):284-6. PubMed ID: 19435149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
